Lantus
Lantus Lantus (insulin glargine) is a long‑acting basal insulin analogue used to maintain basal glycaemic control in patients with type 1 and type 2 diabetes mellitus. --- Mechanism of Action Basal insulin…
Lansoprazole
Lansoprazole Lansoprazole is a proton pump inhibitor (PPI) widely used to reduce gastric acid secretion. It is indicated for the management of gastro‑esophageal reflux disease (GERD), peptic ulcer disease, Zollinger–Ellison…
Lanadelumab
Lanadelumab Lanadelumab (brand name Takhzyro) is a fully human monoclonal antibody that selectively inhibits plasma kallikrein, a key enzyme driving the bradykinin‑mediated vasodilation seen in hereditary angioedema (HAE). It is…
Lamotrigine
Lamotrigine Lamotrigine is a second‑generation antiepileptic with distinctive dual actions on neuronal excitability and glutamate release. It is widely used for epilepsy and bipolar disorder, and its pharmacokinetics are well…
Lamictal
Lamictal Lamictal (lamotrigine) is a non‑sodium‑channel antiepileptic drug primarily used for seizure control and bipolar disorder maintenance. Mechanism of Action Selective blockade of voltage‑gated sodium channels → stabilizes hyperexcitable neuronal…
Lactulose
Lactulose Lactulose is a synthetic disaccharide used primarily for chronic constipation and hepatic encephalopathy. It is classified as a non‑absorbable osmotic laxative that undergoes bacterial fermentation in the colon. Mechanism…
Lacosamide
Lacosamide Lacosamide (brand name Vimpat) is an anticonvulsant approved for the adjunctive treatment of partial‑onset seizures in adults and adolescents. --- Mechanism of Action Selective enhancement of slow inactivation of…
Labetalol
Labetalol Labetalol is a combined α₁‑ and β‑adrenergic antagonist with unique properties that make it a first‑choice agent for acute hypertension and selected cardiovascular emergencies. Mechanism of Action α₁‑Blockade Competitive…
Kynmobi
Kynmobi Kynmobi (KYN‑1001) is a first‑in‑class, oral, selective inhibitor of kynurenine aminotransferase II (KAT II), designed to elevate central kynurenic acid and modulate excitatory neurotransmission. It is currently studied for treatment‑resistant major…
Kyleena
Kyleena Kyleena (levonorgestrel-releasing intrauterine system) is a small, flexible T‑shaped contraceptive device that delivers 0.12 mg levonorgestrel over 5 years. It is FDA‑approved for contraception, menstrual regulation, and certain gynecologic indications. Mechanism…